Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Coxiella burnetii Antibody Prevalence and Risk Factors of Infection in the Human Population of Estonia.

Neare K, Janson M, Hütt P, Lassen B, Viltrop A.

Microorganisms. 2019 Nov 29;7(12). pii: E629. doi: 10.3390/microorganisms7120629.

2.

Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.

Rostok M, Hütt P, Rööp T, Smidt I, Štšepetova J, Salumets A, Mändar R.

Benef Microbes. 2019 Apr 19;10(4):385-393. doi: 10.3920/BM2016.0123. Epub 2019 Mar 18.

PMID:
30882242
3.

The Evolution of Federal Regulation of Human Drugs in the United States: An Historical Essay.

Hutt PB.

Am J Law Med. 2018 May;44(2-3):403-451. doi: 10.1177/0098858818789421. No abstract available.

PMID:
30106657
4.

Induction of neutralizing antibody response against koala retrovirus (KoRV) and reduction in viral load in koalas following vaccination with recombinant KoRV envelope protein.

Olagoke O, Miller D, Hemmatzadeh F, Stephenson T, Fabijan J, Hutt P, Finch S, Speight N, Timms P.

NPJ Vaccines. 2018 Aug 2;3:30. doi: 10.1038/s41541-018-0066-4. eCollection 2018.

5.

The impact of a social prescribing service on patients in primary care: a mixed methods evaluation.

Carnes D, Sohanpal R, Frostick C, Hull S, Mathur R, Netuveli G, Tong J, Hutt P, Bertotti M.

BMC Health Serv Res. 2017 Dec 19;17(1):835. doi: 10.1186/s12913-017-2778-y.

6.

A realist evaluation of social prescribing: an exploration into the context and mechanisms underpinning a pathway linking primary care with the voluntary sector.

Bertotti M, Frostick C, Hutt P, Sohanpal R, Carnes D.

Prim Health Care Res Dev. 2018 May;19(3):232-245. doi: 10.1017/S1463423617000706. Epub 2017 Dec 7.

7.

Assessment of phenotypic and genotypic antibiotic susceptibility of vaginal Lactobacillus sp.

Štšepetova J, Taelma H, Smidt I, Hütt P, Lapp E, Aotäht E, Mändar R.

J Appl Microbiol. 2017 Aug;123(2):524-534. doi: 10.1111/jam.13497.

PMID:
28574626
8.

Serological Evidence of Exposure to Globally Relevant Zoonotic Parasites in the Estonian Population.

Lassen B, Janson M, Viltrop A, Neare K, Hütt P, Golovljova I, Tummeleht L, Jokelainen P.

PLoS One. 2016 Oct 10;11(10):e0164142. doi: 10.1371/journal.pone.0164142. eCollection 2016.

9.

Characterisation of probiotic properties in human vaginal lactobacilli strains.

Hütt P, Lapp E, Štšepetova J, Smidt I, Taelma H, Borovkova N, Oopkaup H, Ahelik A, Rööp T, Hoidmets D, Samuel K, Salumets A, Mändar R.

Microb Ecol Health Dis. 2016 Aug 12;27:30484. doi: 10.3402/mehd.v27.30484. eCollection 2016.

10.

Hepatitis E Virus in Domestic Pigs, Wild Boars, Pig Farm Workers, and Hunters in Estonia.

Ivanova A, Tefanova V, Reshetnjak I, Kuznetsova T, Geller J, Lundkvist Å, Janson M, Neare K, Velström K, Jokelainen P, Lassen B, Hütt P, Saar T, Viltrop A, Golovljova I.

Food Environ Virol. 2015 Dec;7(4):403-12. doi: 10.1007/s12560-015-9210-8. Epub 2015 Jul 4.

PMID:
26141050
11.

Impact of probiotic Lactobacillus plantarum TENSIA in different dairy products on anthropometric and blood biochemical indices of healthy adults.

Hütt P, Songisepp E, Rätsep M, Mahlapuu R, Kilk K, Mikelsaar M.

Benef Microbes. 2015;6(3):233-43. doi: 10.3920/BM2014.0035.

PMID:
25524863
12.

Commemorating the 50th anniversary of the Drug Amendments of 1962.

Hutt PB, Temple R.

Food Drug Law J. 2013;68(4):449-65. No abstract available.

PMID:
24552082
13.

Legal foundations of adaptive licensing.

Oye K, Baird LG, Chia A, Hocking S, Hutt PB, Lee D, Norwalk L, Salvatore V.

Clin Pharmacol Ther. 2013 Sep;94(3):309-11. doi: 10.1038/clpt.2013.95.

PMID:
23963219
14.

Impact of an intercalated BSc on medical student performance and careers: a BEME systematic review: BEME Guide No. 28.

Jones M, Hutt P, Eastwood S, Singh S.

Med Teach. 2013 Oct;35(10):e1493-510. doi: 10.3109/0142159X.2013.806983. Epub 2013 Aug 20. Review.

PMID:
23962229
15.

[Effect of probiotic Heart cheese "Harmony" comprising bacteria L. plantarum TENSIA DSM 21380 on blood pressure and metabolic health indices].

Mikelsaar M, Hutt P, Shchepetova J, Smidt I, Shkut E, Ratsep M, Zilmer M, Songisepp E.

Vopr Pitan. 2012;81(3):74-81. Russian.

PMID:
22888676
16.

Safety of a probiotic cheese containing Lactobacillus plantarum Tensia according to a variety of health indices in different age groups.

Songisepp E, Hütt P, Rätsep M, Shkut E, Kõljalg S, Truusalu K, Stsepetova J, Smidt I, Kolk H, Zagura M, Mikelsaar M.

J Dairy Sci. 2012 Oct;95(10):5495-509. doi: 10.3168/jds.2011-4756. Epub 2012 Aug 3.

17.

Former FDA Chief Counsels roundtable at the 55th Annual Conference of the Food and Drug Law Institute.

Bradshaw ST, Buc NL, Cooper RM, Hutt PB, Masoudi GF, Troy DE, Tyler RS, Baylor-Henry MV.

Food Drug Law J. 2012;67(3):293-310. No abstract available.

PMID:
24624652
18.

Safety and persistence of orally administered human Lactobacillus sp. strains in healthy adults.

Hütt P, Kõll P, Stsepetova J, Alvarez B, Mändar R, Krogh-Andersen K, Marcotte H, Hammarström L, Mikelsaar M.

Benef Microbes. 2011 Mar;2(1):79-90. doi: 10.3920/BM2010.0023.

PMID:
21831792
19.

Disaster in Japan: a new medical gaze.

Hutt P, Kassai R.

Br J Gen Pract. 2011 Jun;61(587):376-7. doi: 10.3399/bjgp11X572616. No abstract available.

20.

Health inequalities: is Japan a paradox?

Hutt P.

Jpn Hosp. 2010 Jul;(29):79-81. No abstract available.

PMID:
21706965
21.

On firm ground: IP protection of therapeutic nanoparticles.

Burgess P, Hutt PB, Farokhzad OC, Langer R, Minick S, Zale S.

Nat Biotechnol. 2010 Dec;28(12):1267-70. doi: 10.1038/nbt.1725. No abstract available.

PMID:
21139609
22.

Immunological, antioxidative, and morphological response in combined treatment of ofloxacin and Lactobacillus fermentum ME-3 probiotic in Salmonella Typhimurium murine model.

Truusalu K, Kullisaar T, Hütt P, Mahlapuu R, Aunapuu M, Arend A, Zilmer M, Mikelsaar RH, Mikelsaar M.

APMIS. 2010 Nov;118(11):864-72. doi: 10.1111/j.1600-0463.2010.02672.x. Epub 2010 Sep 14.

PMID:
20955459
23.

Polyclinics and polysystems: evolving ambiguity, evidence required.

Hutt P, Singh S, Modell M, Nazareth I.

Br J Gen Pract. 2010 Jun;60(575):400-1. doi: 10.3399/bjgp10X502083. No abstract available.

24.

Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probiotics.

Kõll P, Mändar R, Smidt I, Hütt P, Truusalu K, Mikelsaar RH, Shchepetova J, Krogh-Andersen K, Marcotte H, Hammarström L, Mikelsaar M.

Curr Microbiol. 2010 Dec;61(6):560-6. doi: 10.1007/s00284-010-9653-y. Epub 2010 May 5.

PMID:
20443005
25.

Intestinal Lactobacillus sp. is associated with some cellular and metabolic characteristics of blood in elderly people.

Mikelsaar M, Stsepetova J, Hütt P, Kolk H, Sepp E, Lõivukene K, Zilmer K, Zilmer M.

Anaerobe. 2010 Jun;16(3):240-6. doi: 10.1016/j.anaerobe.2010.03.001. Epub 2010 Mar 17.

PMID:
20223288
26.

Family medicine in Japan.

Hutt P.

Br J Gen Pract. 2009 Sep;59(566):699-701. doi: 10.3399/bjgp09X454250. No abstract available.

27.

A UK persepctive.

Hutt P.

Jpn Hosp. 2009 Jul;(28):93-5. No abstract available.

PMID:
21128516
28.

Effects of a synbiotic product on blood antioxidative activity in subjects colonized with Helicobacter pylori.

Hütt P, Andreson H, Kullisaar T, Vihalemm T, Unt E, Kals J, Kampus P, Zilmer M, Mikelsaar M.

Lett Appl Microbiol. 2009 Jun;48(6):797-800. doi: 10.1111/j.1472-765X.2009.02607.x. Epub 2009 Apr 1.

29.

Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.

Hütt P, Shchepetova J, Lõivukene K, Kullisaar T, Mikelsaar M.

J Appl Microbiol. 2006 Jun;100(6):1324-32.

30.

Long-term protection against carriage of hepatitis B virus after infant vaccination.

van der Sande MA, Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, Doherty C, McConkey SJ, Jeffries D, Hall AJ, Whittle HC.

J Infect Dis. 2006 Jun 1;193(11):1528-35. Epub 2006 Apr 25.

PMID:
16652281
31.

FDA statutory authority to regulate the safety of dietary supplements.

Hutt PB.

Am J Law Med. 2005;31(2-3):155-74. No abstract available.

PMID:
16146287
32.

Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers.

Songisepp E, Kals J, Kullisaar T, Mändar R, Hütt P, Zilmer M, Mikelsaar M.

Nutr J. 2005 Aug 4;4:22.

33.

The diagnostic value of endoscopy and Helicobacter pylori tests for peptic ulcer patients in late post-treatment setting.

Maaroos HI, Andreson H, Lõivukene K, Hütt P, Kolk H, Kull I, Labotkin K, Mikelsaar M.

BMC Gastroenterol. 2004 Oct 26;4:27.

34.

A new probiotic cheese with antioxidative and antimicrobial activity.

Songisepp E, Kullisaar T, Hütt P, Elias P, Brilene T, Zilmer M, Mikelsaar M.

J Dairy Sci. 2004 Jul;87(7):2017-23.

35.

Evidence: its meanings in health care and in law. (Summary of the 10 April 2000 IOM and AHRQ Workshop, "Evidence": its meanings and uses in law, medicine, and health care).

Havighurst CC, Hutt PB, McNeil BJ, Miller W.

J Health Polit Policy Law. 2001 Apr;26(2):195-215. No abstract available.

PMID:
11330078
36.
38.

Hb T-Cambodia, a beta chain variant with the mutations of Hb E and Hb D-Punjab, confirmed by DNA analysis.

Hutt PJ, Fairbanks VF, Thibodeau SN, Green MM, Hoyer JD, Block SH, Day C, Jones RT, Barwick RC.

Hemoglobin. 1997 May;21(3):205-18.

PMID:
9140717
39.

Optimizing the review process of food additive and GRAS petitions. Overview of the workshop.

Hutt PB.

Regul Toxicol Pharmacol. 1996 Dec;24(3):242-5. No abstract available.

PMID:
8975753
40.

Hb Cook [beta 132(H10)Lys-->Thr]: a new hemoglobin variant in a southeast Asian family.

Hutt PJ, Fairbanks VF, Griffin TC, Thibodeau SN, Green MM, Hoyer JD.

Hemoglobin. 1996 Nov;20(4):371-6.

PMID:
8936463
41.
42.

Hemoglobin S/hemoglobin Osler: a case with 3 beta globin chains. DNA sequence (AAT) proves that Hb Osler is beta 145 Tyr-->Asn.

Hutt PJ, Donaldson MH, Khatri J, Fairbanks VF, Hoyer JD, Thibodeau SN, Moxness MS, McMorrow LE, Green MM, Jones RT.

Am J Hematol. 1996 Aug;52(4):305-9.

43.

Spinal extradural hematoma in an infant with hemophilia A: an unusual presentation of a rare complication.

Hutt PJ, Herold ED, Koenig BM, Gilchrist GS.

J Pediatr. 1996 May;128(5 Pt 1):704-6. Review.

PMID:
8627448
44.
45.

Standardized teaching plans for management of chemotherapy and radiation therapy side effects.

Myers JS, Davidson J, Hutt P, Chatham S.

Oncol Nurs Forum. 1987 Sep-Oct;14(5):95-9. No abstract available.

PMID:
3658784
46.

The importance of analytical chemistry to food and drug regulation.

Hutt PB.

J Assoc Off Anal Chem. 1985 Mar-Apr;68(2):147-51. No abstract available.

PMID:
3886623
47.

Government regulation of the integrity of the food supply.

Hutt PB.

Annu Rev Nutr. 1984;4:1-20. No abstract available.

PMID:
6380534
48.

Investigations and reports respecting FDA regulation of new drugs (Part II).

Hutt PB.

Clin Pharmacol Ther. 1983 May;33(5):674-87. No abstract available.

PMID:
6340910
49.

Investigations and reports respecting FDA regulation of new drugs (Part I).

Hutt PB.

Clin Pharmacol Ther. 1983 Apr;33(4):537-48. No abstract available.

PMID:
6339149
50.

University/corporate research agreements.

Hutt PB.

Technol Soc. 1983;5(2):107-18. No abstract available.

PMID:
11650686

Supplemental Content

Support Center